Spinal muscular atrophy: A timely review

Archives of Neurology

Volumn 68, Issue 8, 2011, Pages 979-984

  Kolb, Stephen J ^a   Kissel, John T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; HYDROXYUREA; RNA; SURVIVAL MOTOR NEURON PROTEIN 1; TRICHSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID;

ADENOVIRUS; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; GENE; GENE MUTATION; GENE THERAPY; HUMAN; IN VITRO STUDY; MOLECULAR GENETICS; MOLECULAR LIBRARY; MOTONEURON; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMN1 GENE; SMN2 GENE; SPINAL CORD VENTRAL HORN; SPINAL MUSCULAR ATROPHY; SURVIVAL;

ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC PREDISPOSITION TO DISEASE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MUSCULAR ATROPHY, SPINAL; MUTATION; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 80051554264     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.74     Document Type: Review

References (33)

1. Dubowitz V. Ramblings in the history of spinal muscular atrophy. Neuromuscul Disord. 2009;19(1):69-73.
2. Munsat TL. Workshop report: international SMA collaboration. Neuromuscul Disord. 1991;1(2):81. doi:10.1016/0960-8966(91)90052-T.
3. Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155-165.
4. Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med. 2002;4(1):20-26. (Pubitemid 44698460)
5. Prior TW, Krainer AR, Hua Y, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet. 2009;85(3):408-413.
6. Monani UR, Sendtner M, Coovert DD, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy [printed correction appears in Hum Mol Genet. 2007;16(21):2648]. Hum Mol Genet. 2000;9(3):333-339. (Pubitemid 30098725)
7. Schmid A, DiDonato CJ. Animal models of spinal muscular atrophy. J Child Neurol. 2007;22(8):1004-1012. (Pubitemid 47308315)
8. Kolb SJ, Battle DJ, Dreyfuss G. Molecular functions of the SMN complex. J Child Neurol. 2007;22(8):990-994. (Pubitemid 47308313)
9. Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci. 2009;10(8):597-609.
10. Pellizzoni L. Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep. 2007;8(4):340-345. (Pubitemid 46511034)
11. Kolb SJ, Sutton S, Schoenberg DR. RNA processing defects associated with diseases of the motor neuron. Muscle Nerve. 2010;41(1):5-17.
12. Wang CH, Finkel RS, Bertini ES, et al Participants of the International Conference on SMA Standard of Care. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027-1049. (Pubitemid 47308318)
13. Werdnig G. Zwei fruhinfantile hereditare Falle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber auf neurotischer Grundlage. Arch Psychiatr Nervenkr. 1891;22:437-480.
14. Hoffmann J. Uber chronische spinale Muskelatrophie im Kindersalter auf familiarer Basis. Deut Zeitsch Nervenheilkd. 1893;3(6):427-470. doi:10.1007/BF01668496.
15. Kugelberg E, Welander L. Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. AMA Arch Neurol Psychiatry. 1956;75(5):500-509.
16. Dubowitz V. Infantile muscular atrophy: a broad spectrum. Clin Proc Child Hosp Dist Columbia. 1967;23(8):223-239.
17. Andreassi C, Jarecki J, Zhou J, et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet. 2001;10(24):2841-2849. (Pubitemid 34026465)
18. Lim SR, Hertel KJ. Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J Biol Chem. 2001;276(48):45476-45483.
19. Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A. 2001;98(17):9808-9813. (Pubitemid 32769385)
20. Mercuri E, Bertini E, Messina S, et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology. 2007;68(1):51-55. (Pubitemid 46058552)
21. Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82(4):834-848.
22. Dickson A, Osman E, Lorson CL. A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo. Hum Gene Ther. 2008;19(11):1307-1315.
23. Coady TH, Baughan TD, Shababi M, Passini MA, Lorson CL. Development of a single vector system that enhances trans-splicing of SMN2 transcripts. PLoS One. 2008;3(10):e3468.
24. Foust KD, Wang X, McGovern VL, et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol. 2010;28:271-274. doi:10.1038/nbt.1610.
25. Passini MA, Bu J, Roskelley EM, et al. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J Clin Invest. 2010;120(4):1253-1264.
26. Dominguez E, Marais T, Chatauret N, et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet. 2011;20(4):681-693.
27. Singh NK, Singh NN, Androphy EJ, Singh RN. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol. 2006;26(4):1333-1346. (Pubitemid 43202560)
28. Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ. Oligonucleotide- mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci. 2009;29(24):7633-7638.
29. Hua Y, Sahashi K, Hung G, et al. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev. 2010;24(15):1634-1644.
30. Baughan TD, Dickson A, Osman EY, Lorson CL. Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. Hum Mol Genet. 2009;18(9):1600-1611.
31. Coady TH, Lorson CL. Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy. J Neurosci. 2010;30(1):126-130.
32. Valori CF, Ning K, Wyles M, et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med. 2010;2(35):35ra42.
33. Prior TW, Snyder PJ, Rink BD, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A. 2010;152A(7):1608-1616.